RK-002

N/A

Report date: 2023/07/07 17:35:33

Base Information

Drug NameRK-002
Drug Alias NameRK-002
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRevolKa Ltd
China Registration ClassN/A

Develop Information

Active CompaniesRevolKa Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A